Bryan, Garnier & Co Stock Recommendations and Price Targets

This is a list of recent ratings by Bryan, Garnier & Co.

DateCompany NameActionCurrent
Price
Price
Target
Rating
11/7/2024
NKLAQ
Nikola
Downgrade$0.00Buy ➝ Neutral
5/16/2024
NKLAQ
Nikola
Initiated Coverage$0.00 $30.00Buy
9/14/2023
MLTX
MoonLake Immunotherapeutics
Downgrade$13.00Buy ➝ Neutral
5/5/2023
TVTX
Travere Therapeutics
Upgrade$35.00Sell ➝ Neutral
3/24/2023
IMTX
Immatics
Initiated Coverage$10.00 $16.00Buy
3/24/2023
IMCR
Immunocore
Initiated Coverage$36.00 $16.00Buy
3/17/2023
CLLS
Cellectis
Initiated Coverage$4.00 $6.00Buy
3/17/2023
AUTL
Autolus Therapeutics
Initiated Coverage$2.00 $5.00Buy
3/17/2023
CRSP
CRISPR Therapeutics
Initiated Coverage$56.00 $70.00Buy
2/2/2023
MLTX
MoonLake Immunotherapeutics
Initiated Coverage$13.00 $22.00Buy